# Cara Therapeutics, Inc.: Form D filings

Cara Therapeutics, Inc., a biotechnology company in Shelton, CT, filed 2 Form D notices with the SEC between 2010 and 2014. The latest, on December 11, 2014, reports $100,003 sold of a $100,003 offering to 1 investor.

Find out what Cara Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Cara%20Therapeutics%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Cara%20Therapeutics%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fcara-therapeutics-inc-1346830)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Cara%20Therapeutics%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Cara%20Therapeutics%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fcara-therapeutics-inc-1346830)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Connecticut](https://specstream.ai/data/form-d/state/connecticut): 428 rows, by operating companies, filed since November 1, 2024, $21.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/connecticut
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: ONE PARROTT DRIVE, Shelton, CT, 06484
- Phone: (203) 567-1500
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: $5,000,001 - $25,000,000
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1346830

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Dec 11, 2014 | New notice | $100,003 | $100,003 | $0 | 1 | Dec 1, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1346830/000123191914000039/0001231919-14-000039-index.htm) |
| Jul 21, 2010 | New notice | $15,000,000 | $4,784,568 | $10,215,432 | 12 | Jul 19, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1346830/000134683010000003/0001346830-10-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Josef Schoell | Executive Officer |  |
| Jeffrey L. Ives | Director |  |
| Joseph W. Stauffer | Executive Officer |  |
| Derek Chalmers | Executive Officer, Director |  |
| Michael E. Lewis | Executive Officer |  |
| Martin Vogelbaum | Director |  |
| Dean Slagel | Director |  |
| Frederique Menzaghi | Executive Officer |  |
| Harrison Bains | Director |  |

## Other biotechnology companies in Connecticut that filed recently

- [Allyx Therapeutics, Inc.](https://specstream.ai/data/form-d/company/allyx-therapeutics-inc-1865257) $27.9 million · Oct 21, 2026
- [Cloverleaf Bio, Inc.](https://specstream.ai/data/form-d/company/cloverleaf-bio-inc-2153574) $14.8 million · Sep 9, 2026

[Every Form D from the week of Dec 8, 2014](https://specstream.ai/data/form-d/week/2014-12-08) · [All recent filings in Connecticut](https://specstream.ai/data/form-d/state/connecticut) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Cara Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).